The FDA typically demands data showing reduced morbidity or improved quality of life
This is consistent with previous studies reporting reduced alcohol craving after GLP-1RA semaglutide administration 22
Many users appreciate the appetite control effects, noting fewer cravings and easier portion management
Strive tells NPR it will fight back, and Empower says in a statement posted to its website, "We stand by our mission, and the patients and providers who depend on it." Scott Brunner, the CEO of the Alliance for Pharmacy Compounding, an advocacy group for compounding pharmacies, declined to comment on the specific suits or companies
Any use of tirzepatide in addiction contexts must be supervised by healthcare providers coordinating with addiction medicine specialists
At Mason Park Medical Clinic in Katy, TX, we understand that weight loss is a deeply personal and often challenging journey